Daan Gene Co., Ltd. (SHE:002030)
China flag China · Delayed Price · Currency is CNY
6.88
-0.42 (-5.75%)
May 12, 2026, 3:04 PM CST

Daan Gene Balance Sheet

Millions CNY. Fiscal year is Jan - Dec.
Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Mar '26 Dec '25 Dec '24 Jan '24 Jan '23 Jan '22
Cash & Equivalents
512.39506.29872.09999.372,5942,179
Short-Term Investments
--858.761,310485.37-
Trading Asset Securities
590593.896390.08480.9380.01
Cash & Short-Term Investments
1,1021,1001,7942,4003,5612,559
Cash Growth
23.75%-38.67%-25.25%-32.61%39.15%45.53%
Accounts Receivable
723.62751.091,3182,1704,2472,352
Other Receivables
25.7126.3433.625052.7656.46
Receivables
749.33777.431,4612,3534,4452,525
Inventory
147.2147.58198.21239.52369.6493.72
Other Current Assets
800.82818.4328.66318.19393.98407.6
Total Current Assets
2,8002,8443,7825,3108,7695,985
Property, Plant & Equipment
1,4821,5001,7901,9031,767863.06
Long-Term Investments
1,3711,4422,5372,5173,0702,703
Other Intangible Assets
396.12418.39572.72279.7204.12115.03
Long-Term Accounts Receivable
--87.4735.9172.0516.62
Long-Term Deferred Tax Assets
344.02344.36358.39228.9199.34112.69
Long-Term Deferred Charges
288.7291.23397.58670.48574.92331.52
Other Long-Term Assets
1,6261,64434.3957.2199.95209.08
Total Assets
8,3348,5119,57711,01814,75710,336
Accounts Payable
251.5259.68357.87425.44737.07553.01
Accrued Expenses
390.25451.21569.74760.131,559985.63
Short-Term Debt
120.1103.79143.53330.8117.76282.59
Current Portion of Long-Term Debt
7.267.57----
Current Portion of Leases
--6.9513.2142.6645.32
Current Income Taxes Payable
35.8532.7928.1229.69302383.47
Current Unearned Revenue
34.7235.1166.2334.2369.34152.45
Other Current Liabilities
99.74117.23121.3127.58140.9118.58
Total Current Liabilities
939.421,0071,2941,7212,9692,521
Long-Term Leases
3.193.3713.4621.8167.3876.15
Long-Term Unearned Revenue
38.8244.9458.5332.6927.2730.14
Long-Term Deferred Tax Liabilities
59.2463.8861.2479.8547.9746.97
Other Long-Term Liabilities
26.8826.156.935.4129.82.17
Total Liabilities
1,0681,1461,4341,8613,1412,676
Common Stock
1,4031,4031,4031,4031,4031,403
Additional Paid-In Capital
601.69601.69600.97651.54719.99621.38
Retained Earnings
5,0405,1395,8836,8299,1815,326
Comprehensive Income & Other
-5.88-5.84-7.41-3.92-2.850.5
Total Common Equity
7,0407,1387,8808,88011,3017,351
Minority Interest
227.26226.92263.07276.83314.79308.63
Shareholders' Equity
7,2677,3658,1439,15711,6167,660
Total Liabilities & Equity
8,3348,5119,57711,01814,75710,336
Total Debt
130.55114.73163.94365.83227.8404.06
Net Cash (Debt)
971.84985.461,6302,0343,3332,155
Net Cash Growth
27.93%-39.54%-19.86%-38.98%54.66%60.03%
Net Cash Per Share
0.680.701.161.362.371.54
Filing Date Shares Outstanding
1,4021,3731,4031,4031,4031,403
Total Common Shares Outstanding
1,4021,3731,4031,4031,4031,403
Working Capital
1,8601,8362,4883,5895,8003,464
Book Value Per Share
5.025.205.616.338.055.24
Tangible Book Value
6,6446,7197,3078,60111,0977,236
Tangible Book Value Per Share
4.744.895.216.137.915.16
Buildings
--807.22766.64618.81293.09
Machinery
--1,1411,1551,017591.94
Construction In Progress
315.08-776.1727.35576.63210.65
Source: S&P Global Market Intelligence. Standard template. Financial Sources.